Literature DB >> 10364174

Interaction of granulocyte colony-stimulating factor (G-CSF) with its receptor. Evidence that Glu19 of G-CSF interacts with Arg288 of the receptor.

J E Layton1, G Shimamoto, T Osslund, A Hammacher, D K Smith, H R Treutlein, T Boone.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) forms a tetrameric complex with its receptor, comprising two G-CSF and two receptor molecules. The structure of the complex is unknown, and it is unclear whether there are one or two binding sites on G-CSF and the receptor. The immunoglobulin-like domain and the cytokine receptor homologous module of the receptor are involved in G-CSF binding, and Arg288 in the cytokine receptor homologous module is particularly important. To identify residues in G-CSF that interact with Arg288, selected charged residues in G-CSF were mutated to Ala. To clarify whether there are two binding sites, a chimeric receptor was created in which the Ig domain was replaced with that of the related receptor gp130. This chimera bound G-CSF but could not transduce a signal, consistent with failure of dimerization and loss of one binding site. The G-CSF mutants had reduced mitogenic activity on cells expressing wild-type receptor. When tested with the chimeric receptor, all G-CSF mutants except one (E46A) showed reduced binding, suggesting that Glu46 is important for interaction with the Ig domain. On cells expressing R288A receptor, all the G-CSF mutants except E19A showed reduced mitogenic activity, indicating that Glu19 of G-CSF interacts with Arg288 of the receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364174     DOI: 10.1074/jbc.274.25.17445

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Crystallization of a 2:2 complex of granulocyte-colony stimulating factor (GCSF) with the ligand-binding region of the GCSF receptor.

Authors:  Eijiro Honjo; Taro Tamada; Yoshitake Maeda; Takumi Koshiba; Yasuko Matsukura; Tomoyuki Okamoto; Matsujiro Ishibashi; Masao Tokunaga; Ryota Kuroki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-07-30

2.  A cell-level model of pharmacodynamics-mediated drug disposition.

Authors:  Wojciech Krzyzanski; John M Harrold; Liviawati S Wu; Juan Jose Perez-Ruixo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-09       Impact factor: 2.745

3.  Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.

Authors:  R N Jorissen; V C Epa; H R Treutlein; T P Garrett; C W Ward; A W Burgess
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

4.  Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.

Authors:  Sabine Le Saux; François Rousseau; Fabien Barbier; Elisa Ravon; Linda Grimaud; Yannic Danger; Josy Froger; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex.

Authors:  Taro Tamada; Eijiro Honjo; Yoshitake Maeda; Tomoyuki Okamoto; Matsujiro Ishibashi; Masao Tokunaga; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  Characterization of stress-exposed granulocyte colony stimulating factor using ELISA and hydrogen/deuterium exchange mass spectrometry.

Authors:  Daisuke Tsuchida; Katsuyoshi Yamazaki; Satoko Akashi
Journal:  J Am Soc Mass Spectrom       Date:  2014-07-29       Impact factor: 3.109

7.  Effect of a structurally modified human granulocyte colony stimulating factor, G-CSFa, on leukopenia in mice and monkeys.

Authors:  Yongping Jiang; Wenhong Jiang; Yuchang Qiu; Wei Dai
Journal:  J Hematol Oncol       Date:  2011-06-13       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.